FDA Panel Recommends Approval of BENLYSTA® for Treating Systemic Lupus

Now that you've read the official statement from the LFA about yesterday's historical FDA hearing for Benlysta®, watch as Sandra C. Raymond, President and CEO of Lupus Foundation of America, and Dr. Gary Gilkeson, Chair of the LFA's Medical-Scientific Advisory Council, react to yesterday's events.